The overall survival time in AML patients with high DDIT4 level (n = 57) was significantly shorter than that of those with low DDIT4 expression (n = 56) (P < 0.01, Fig. 2C), indicating that a higher DDIT4 level in leukemia cells is associated with worse prognosis. Here, DDIT4 is linked to acute myeloid leukemia.